CRABP2 and breast cancer: The expression of CRABP2 was significantly higher in breast cancer than normal controls in subgroup analysis based on gender, age, menopause status, disease stage, nodal metastasis status, and molecular subtypes (all P < 0.05, Fig. 4a).